In the blood of Behçet disease patients, an elevated level of IL-17 was described more frequently in those developing neurological involvement and is considered as a marker of disease progression (Al-Zifzaf et al., 2015; Belghith et al., 2018). This evidence concerns the gene IL17A and Behcet disease.